Purpura Latest Advances

Efficacy and Safety of Remibrutinib in Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis.

Journal: American journal of therapeutics

Published: October 17, 2025

Intravenous immunoglobulins in Henoch-Schönlein purpura with severe gastrointestinal involvement. Case report and review of the literature.

Journal: International journal of immunopathology and pharmacology

Published: October 15, 2025

Resolution of thrombotic thrombocytopenic purpura serous retinal detachment following rituximab therapy.

Journal: Retinal cases & brief reports

Published: October 14, 2025

The comparative immunophenotypic analysis of paediatric and adults bone marrow lymphocytes' in chronic Immune thrombocytopenic purpura (ITP) refractory to intravenous immunoglobulin and corticosteroids.

Journal: The Egyptian journal of immunology

Published: October 14, 2025

Interpretation of the clinical practice guidelines for adult patients with IgA nephropathy and IgA vasculitis-associated nephritis in China (2025)

Journal: Zhonghua nei ke za zhi

Published: October 13, 2025

Rilzabrutinib and Bruton tyrosine kinase inhibition for the treatment of persistent or chronic immune thrombocytopenia.

Journal: Expert opinion on pharmacotherapy

Published: October 13, 2025

Analysis of diagnostic value of lncRNA HCP5 in immune thrombocytopenia and its predictive value for disease progression.

Journal: Expert review of hematology

Published: October 10, 2025

Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey: Erratum.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: October 09, 2025

Evaluation of Hemato-Inflammatory Parameters NLR, PLR and HPR in Patients with Immune Thrombocytopenic Purpura (ITP) in South-East Iran: A Retrospective Study.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: October 06, 2025

Brutons tyrosine kinase inhibitor Zanubrutinib modulates Fc gamma receptors to inhibit platelet destruction for alleviation of refractory immune thrombocytopenia.

Journal: Hematology (Amsterdam, Netherlands)

Published: October 06, 2025

Partial Splenic Angioembolization for Refractory Chronic Immune Thrombocytopenia: A Case Report.

Journal: Acta medica Philippina

Published: October 03, 2025

Clinical management of pigmented purpuric dermatoses: evidence from a survey among the Study Group on Cutaneous Vascular Diseases of the Italian Society of Dermatology and Venereology.

Journal: Italian journal of dermatology and venereology

Published: October 03, 2025

Filters

Efficacy and Safety of Remibrutinib in Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis.

Efficacy and Safety of Remibrutinib in Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis.

Intravenous immunoglobulins in Henoch-Schönlein purpura with severe gastrointestinal involvement. Case report and review of the literature.

Intravenous immunoglobulins in Henoch-Schönlein purpura with severe gastrointestinal involvement. Case report and review of the literature.

Resolution of thrombotic thrombocytopenic purpura serous retinal detachment following rituximab therapy.

Resolution of thrombotic thrombocytopenic purpura serous retinal detachment following rituximab therapy.

The comparative immunophenotypic analysis of paediatric and adults bone marrow lymphocytes' in chronic Immune thrombocytopenic purpura (ITP) refractory to intravenous immunoglobulin and corticosteroids.

The comparative immunophenotypic analysis of paediatric and adults bone marrow lymphocytes' in chronic Immune thrombocytopenic purpura (ITP) refractory to intravenous immunoglobulin and corticosteroids.

Interpretation of the clinical practice guidelines for adult patients with IgA nephropathy and IgA vasculitis-associated nephritis in China (2025)

Interpretation of the clinical practice guidelines for adult patients with IgA nephropathy and IgA vasculitis-associated nephritis in China (2025)

Rilzabrutinib and Bruton tyrosine kinase inhibition for the treatment of persistent or chronic immune thrombocytopenia.

Rilzabrutinib and Bruton tyrosine kinase inhibition for the treatment of persistent or chronic immune thrombocytopenia.

Analysis of diagnostic value of lncRNA HCP5 in immune thrombocytopenia and its predictive value for disease progression.

Analysis of diagnostic value of lncRNA HCP5 in immune thrombocytopenia and its predictive value for disease progression.

Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey: Erratum.

Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey: Erratum.

Evaluation of Hemato-Inflammatory Parameters NLR, PLR and HPR in Patients with Immune Thrombocytopenic Purpura (ITP) in South-East Iran: A Retrospective Study.

Evaluation of Hemato-Inflammatory Parameters NLR, PLR and HPR in Patients with Immune Thrombocytopenic Purpura (ITP) in South-East Iran: A Retrospective Study.

Brutons tyrosine kinase inhibitor Zanubrutinib modulates Fc gamma receptors to inhibit platelet destruction for alleviation of refractory immune thrombocytopenia.

Brutons tyrosine kinase inhibitor Zanubrutinib modulates Fc gamma receptors to inhibit platelet destruction for alleviation of refractory immune thrombocytopenia.

Partial Splenic Angioembolization for Refractory Chronic Immune Thrombocytopenia: A Case Report.

Partial Splenic Angioembolization for Refractory Chronic Immune Thrombocytopenia: A Case Report.

Clinical management of pigmented purpuric dermatoses: evidence from a survey among the Study Group on Cutaneous Vascular Diseases of the Italian Society of Dermatology and Venereology.

Clinical management of pigmented purpuric dermatoses: evidence from a survey among the Study Group on Cutaneous Vascular Diseases of the Italian Society of Dermatology and Venereology.